Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle Delivery System-Reference-Cited by-同舟云学术

Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle Delivery System

Published:2021-05-06 Issue:8 Volume:17 Page:2501-2516
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Wan Ying¹,Gupta Vineet¹,Bird Christopher¹,Pullagurla Swathi R.¹,Fahey Paul²,Forster Angus²,Volkin David B.¹,Joshi Sangeeta B.¹

Affiliation:

1. Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA

2. Vaxxas Pty Ltd, Translational Research Institute, Brisbane, QLD, Australia

Funder

Bill and Melinda Gates Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1887692

Reference61 articles.

1. Structure, Transcription, and Replication of Measles Virus

2. Molecular Biology of Rubella Virus

3. World Health Organization. Measles vaccines: WHO position paper; 2017 [accessed 17 Jan 2021]. https://apps.who.int/iris/bitstream/handle/10665/255149/WER9217.pdf?sequence=1.

4. World Health Organization. Rubella vaccines: WHO position paper; 2020 [accessed 17 Jan 2021]. https://apps.who.int/iris/bitstream/handle/10665/332950/WER9527-eng-fre.pdf?ua=1.

5. MMR and MMRV vaccines

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial;Vaccines;2023-11-17

2. Exploiting Unique Features of Microneedles to Modulate Immunity;Advanced Materials;2023-11-05

3. Microarray patches: scratching the surface of vaccine delivery;Expert Review of Vaccines;2023-10-27

4. Living virus‐based nanohybrids for biomedical applications;WIREs Nanomedicine and Nanobiotechnology;2023-08-24

5. Analytical considerations to support expeditious formulation development of vaccines;Bioanalysis;2023-06